Vacuolar-type H+-ATPase-mediated proton transport in the rat parietal cell.
Sascha Kopic, Maximilian E H Wagner, Christoph Griessenauer, Thenral Socrates, Markus Ritter, John P Geibel
Index: Pflugers Arch. 463(3) , 419-27, (2012)
Full Text: HTML
Abstract
The vacuolar-type H-ATPase (V-ATPase) plays an important role in the active acidification of intracellular organelles. In certain specialized cells, such as the renal intercalated cell, apical V-ATPase can also function as a proton secretion pathway. In the parietal cells of the stomach, it has been thought that acid secretion is controlled solely via the H,K-ATPase. However, recent observations suggest that functional V-ATPase is necessary for acid secretion to take place. This study aimed to investigate and characterize the role of V-ATPase in parietal cell proton transport. Individual rat gastric glands were incubated with the pH-sensitive dye (BCECF) to monitor changes in intracellular pH in real time. Parietal cell V-ATPase activity was measured by quantifying the rate of intracellular alkalinization (ΔpH/minute) following an acid load, while excluding the contribution of non-V-ATPase proton transport mechanisms through pharmacological inhibition or ion substitution. Expression of V-ATPase was confirmed by immunohistochemistry. We observed concanamycin A-sensitive V-ATPase activity in rat parietal cells following intracellular acidification and H,K-ATPase inhibition. Furthermore, V-ATPase-mediated proton transport could be abolished by inhibiting trafficking mechanisms with paclitaxel and by stimulating H,K-ATPase with acid secretagogues. Our results propose that parietal cells contain a functional V-ATPase that can be mobilized using a microtubule network. V-ATPase may function as an auxiliary acid secretion or proton-buffering pathway in parietal cells, which is inactive during H,K-ATPase activity. Our findings may have important implications for patients experiencing acid breakthrough under proton pump inhibitor therapy.
Related Compounds
Related Articles:
2014-09-01
[Aquat. Toxicol. 154 , 12-8, (2014)]
2013-01-15
[Int. J. Cancer 132(2) , E1-10, (2013)]
2012-01-01
[PLoS ONE 7(6) , e39569, (2012)]
2008-10-15
[Cancer Res. 68 , 8456-64, (2008)]
2009-05-01
[Cancer Immunol. Immunother. 58(5) , 709-18, (2009)]